Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women.

OBJECTIVE The study was undertaken to identify early pregnancy vaginal markers predictive of subsequent preterm birth. STUDY DESIGN In a multicenter Bacterial Vaginosis (BV) Trial, 21,554 women were screened with a vaginal pH and of these, two populations were studied. These included 12,041 who had a pregnancy outcome in the database and 6838 women who had a vaginal pH of 4.5 or greater and a Gram stain score and a pregnancy outcome in the database. ColorpHast Indicator Strips were used to determine the vaginal pH and the Nugent criteria were used to determine a vaginal Gram stain score of 0 to 10. RESULTS Delivery at <37, <35, or <32 weeks' gestation was similar for women with a vaginal pH of less than 4.4 or 4.7 (P not significant) but was increased in women with a pH of 5.0 (P =.04,.02,.03, respectively) or with a pH of 5.0 or greater (at each gestational age P <.0001). The effect of pH of 5.0 or greater was similar for women who had a spontaneous preterm birth at each gestational age (P <.0001) or birth weight of less than 2500 g or less than 1500 g (P <.0005). Women with a vaginal pH of 4.5 or greater and a Gram stain score of 9 to 10 (compared with 0-8) had increased preterm births at <37, <35, and <32 weeks' gestation (P <.01), and birth weights less than 2500 g (P <.0001) or less than 1500 g (P <.01). Women whose vaginal pH was 5.0 or greater had a higher prevalence of vaginal fetal fibronectin > or =50 ng/mL (P <.0001), but the proportion of women with a vaginal fetal fibronectin > or =50 mg/mL did not differ by Gram stain score. CONCLUSION Women with a vaginal pH of 5.0 or greater or a vaginal pH of 4.5 or greater and a Gram stain score of 9 to 10 had significantly increased preterm births at <37, <35, and 32 weeks' gestation and/or a birth weight less than 2500 g or less than 1500 g.

[1]  John A. Albritton,et al.  Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. , 1994, American journal of obstetrics and gynecology.

[2]  T. P. Jackson,et al.  Race/ethnicity, vaginal flora patterns, and pH during pregnancy. , 1999, Sexually transmitted diseases.

[3]  R. Gibbs,et al.  Evidence relating bacterial vaginosis to intraamniotic infection. , 1989, American journal of obstetrics and gynecology.

[4]  J. French,et al.  Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. , 1994, American journal of obstetrics and gynecology.

[5]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[6]  M. Krohn,et al.  Characteristics of three vaginal flora patterns assessed Gram stain among pregnant women , 1992 .

[7]  S. Hillier,et al.  Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. , 1995, American journal of obstetrics and gynecology.

[8]  W. Andrews,et al.  Bacterial vaginosis: association with adverse pregnancy outcome. , 1998, Seminars in perinatology.

[9]  B. Sibai,et al.  Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth. , 2000, American journal of obstetrics and gynecology.

[10]  M. Krohn,et al.  The Genital Flora of Women with Intraamniotic Infection , 1995 .

[11]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[12]  Ichael,et al.  Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 2000, The New England journal of medicine.

[13]  P. McDonald,et al.  Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial , 1997, British journal of obstetrics and gynaecology.

[14]  M A Krohn,et al.  The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  E. Thom,et al.  The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1995, American journal of obstetrics and gynecology.

[16]  J. Hauth,et al.  Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis , 1995, The New England journal of medicine.

[17]  N. Padian,et al.  Plasma Cell Endometritis in Women With Symptomatic Bacterial Vaginosis , 1995, Obstetrics and gynecology.